Influence of abdominal obesity on vascular endothelial function in overweight/obese adult men

Obesity

Volumn 19, Issue 9, 2011, Pages 1742-1746

  Weil, Brian R ^a   Stauffer, Brian L ^a,b,c   Mestek, Michael L ^a   Desouza, Christopher A ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BRADYKININ; NITROPRUSSIDE SODIUM; TISSUE PLASMINOGEN ACTIVATOR;

ABDOMINAL OBESITY; ADULT; ARM BLOOD FLOW; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CORRELATIONAL STUDY; ENDOTHELIAL DYSFUNCTION; FIBRINOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; VASCULAR ENDOTHELIUM; VASODILATATION; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADIPOSITY; BIOLOGICAL MARKERS; BODY MASS INDEX; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; OBESITY; OBESITY, ABDOMINAL; OVERWEIGHT; PLASMINOGEN ACTIVATOR INHIBITOR 1; REGIONAL BLOOD FLOW; TISSUE PLASMINOGEN ACTIVATOR; VASODILATION; VASODILATOR AGENTS; WAIST CIRCUMFERENCE;

EID: 80052172264     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.189     Document Type: Article

References (38)

1. Van Guilder GP, Stauffer BL, Greiner JJ, Desouza CA. Impaired endotheliumdependent vasodilation in overweight and obese adult humans is not limited to muscarinic receptor agonists. Am J Physiol Heart Circ Physiol 2008;294:H1685-H1692. (Pubitemid 351490599)
2. Perticone F, Ceravolo R, Candigliota M et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes 2001;50:159-165. (Pubitemid 32047995)
3. Van Guilder GP, Hoetzer GL, Smith DT et al. Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise. Am J Physiol Endocrinol Metab 2005;289:E807-E813. (Pubitemid 41504380)
4. McGill HC Jr, McMahan CA, Herderick EE et al.; Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002;105:2712-2718. (Pubitemid 34615140)
5. Must A, Spadano J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-1529. (Pubitemid 29504045)
6. Singhal A. Endothelial dysfunction: role in obesity-related disorders and the early origins of CVD. Proc Nutr Soc 2005;64:15-22. (Pubitemid 40685747)
7. Meyers MR, Gokce N. Endothelial dysfunction in obesity: etiological role in atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2007;14:365-369. (Pubitemid 47368087)
8. Brook RD, Bard RL, Rubenfire M, Ridker PM, Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 2001;88:1264-1269. (Pubitemid 33132095)
9. Williams IL, Chowienczyk PJ, Wheatcroft SB et al. Effect of fat distribution on endothelial-dependent and endothelial-independent vasodilatation in healthy humans. Diabetes Obes Metab 2006;8:296-301.
10. Arcaro G, Zamboni M, Rossi L et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 1999;23:936-942. (Pubitemid 29423936)
11. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32(Suppl 1):S62-S67.
12. Fedder DO, Koro CE, L'Italien GJ. New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatmenteligible population. Circulation 2002;105:152-156. (Pubitemid 34084311)
13. Chobanian AV, Bakris GL, Black HR et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572. (Pubitemid 37430158)
14. Lohman TG, Roche AF, Mortorelli R. Anthropometric Standardization Reference Manual. Human Kinetics: Champaign, IL, 1988.
15. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
16. DeSouza CA, Clevenger CM, Greiner JJ et al. Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans. J Physiol (Lond) 2002;542:255-262. (Pubitemid 35190287)
17. Chaplin H Jr, Mollison PL. Correction for plasma trapped in the red cell column of the hematocrit. Blood 1952;7:1227-1238.
18. Macko RF, Ameriso SF, Gruber A et al. Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke 1996;27:2005-2011. (Pubitemid 26372571)
19. Li C, Ford ES, McGuire LC, Mokdad AH. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring) 2007;15:216-224. (Pubitemid 46219802)
20. Yusuf S, Hawken S, Ounpuu S et al.; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-1649. (Pubitemid 41552419)
21. Canoy D, Boekholdt SM, Wareham N et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation 2007;116:2933-2943. (Pubitemid 350291200)
22. Votruba SB, Jensen MD. Regional fat deposition as a factor in FFA metabolism. Annu Rev Nutr 2007;27:149-163. (Pubitemid 351373352)
23. Mathieu P, Lemieux I, Després JP. Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther 2010;87:407-416.
24. Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48. (Pubitemid 47016245)
25. de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007;28:850-856. (Pubitemid 47343598)
26. Mahabadi AA, Massaro JM, Rosito GA et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 2009;30:850-856.
27. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007;115:1285-1295. (Pubitemid 46594773)
28. Yasue H, Matsuyama K, Matsuyama K et al. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 1990;81:482-490. (Pubitemid 20055956)
29. Oliver JJ, Webb DJ, Newby DE. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol 2005;25:2470-2479. (Pubitemid 43732266)
30. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111:363-368. (Pubitemid 40165345)
31. Robinson SD, Ludlam CA, Boon NA, Newby DE. Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2007;27: 1651-1656. (Pubitemid 46986123)
32. Mestek ML, Westby CM, Van Guilder GP et al. Regular aerobic exercise, without weight loss, improves endothelium-dependent vasodilation in overweight and obese adults. Obesity (Silver Spring) 2010;18:1667-1669.
33. Van Guilder GP, Hoetzer GL, Dengel DR, Stauffer BL, DeSouza CA. Impaired endothelium-dependent vasodilation in normotensive and normoglycemic obese adult humans. J Cardiovasc Pharmacol 2006;47:310-313. (Pubitemid 44384071)
34. Parikh NI, Keyes MJ, Larson MG et al. Visceral and subcutaneous adiposity and brachial artery vasodilator function. Obesity (Silver Spring) 2009;17:2054-2059.
35. Onat A, Avci GS, Barlan MM et al. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord 2004;28:1018-1025. (Pubitemid 38998708)
36. National Institutes of Health. Clinical Guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998;6(Suppl 2):51S-209S.
37. Stauffer BL, Hoetzer GL, Van Guilder GP, Smith DT, Desouza CA. Gender differences in endothelial tissue-type plasminogen activator release in middle-aged adults. J Am Coll Cardiol 2005;45:1547-1549. (Pubitemid 40615633)
38. Stauffer BL, Westby CM, Greiner JJ, Van Guilder GP, Desouza CA. Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults. Am J Physiol Regul Integr Comp Physiol 2010;298: R261-R265.